resolvin D1 RvD1
Selected indexed studies
- Resolvin D1 reprograms energy metabolism to promote microglia to phagocytize neutrophils after ischemic stroke. (Cell Rep, 2023) [PMID:37285269]
- Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASH. (bioRxiv, 2024) [PMID:38712196]
- Aspirin-Triggered Resolvin D1 (AT-RvD1) Protects Mouse Skin against UVB-Induced Inflammation and Oxidative Stress. (Molecules, 2023) [PMID:36903662]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Resolvin D1 reprograms energy metabolism to promote microglia to phagocytize neutrophils after ischemic stroke. (2023) pubmed
- Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASH. (2024) pubmed
- Aspirin-Triggered Resolvin D1 (AT-RvD1) Protects Mouse Skin against UVB-Induced Inflammation and Oxidative Stress. (2023) pubmed
- Resolvin D1 (Rvd1) Attenuates In Vitro LPS-Stimulated Inflammation Through Downregulation of miR-155, miR -146, miR -148 and Krupple Like Factor 5. (2024) pubmed
- 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury. (2022) pubmed
- Resolvin D1-mediated cellular crosstalk protects against MASH. (2025) pubmed
- Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition. (2024) pubmed
- Anti-inflammatory actions of aspirin-triggered resolvin D1 (AT-RvD1) in bronchial epithelial cells stimulated by cigarette smoke extract. (2024) pubmed
- Resolvin D1 modulates periodontal ligament fibroblast function. (2023) pubmed
- Structural basis for the access and binding of resolvin D1 (RvD1) to formyl peptide receptor 2 (FPR2/ALX), a class A GPCR. (2024) pubmed